Helping low-income adults with type 1 diabetes start continuous glucose monitoring
Tests a support program to help low-income adults with type 1 diabetes use glucose sensors.
Key facts
- Who runs it
- University of Connecticut
- Where
- Middletown and Vero Beach, United StatesSee the 2 sites
- Trial code
- Registry title
- Pilot RCT: FQHC Intervention for Uptake of CGM in Low-Income Adults With T1D
- Status
- Enrolling by invitation
- People taking part
- 30 people, planned
- Started
- 28 May 2024
- Planned end
- 1 Aug 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- CGM Intervention
- SMBG Control Condition
- Record updated
- 12 August 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for low-income adults with type 1 diabetes who get care at a federally qualified health center. It tests ways to help them start using a continuous glucose monitor (CGM).
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Documented diagnosis of type 1 diabetes (T1D)
- Earlier treatment
- If a person has used a CGM before or uses one now, they must report difficulty using it.
Main reasons for not taking part
- Pregnancy or planning to become pregnant
- Breastfeeding (lactation)
- Serious illness that may prevent taking part (for example severe depression)
- Less than 6 months life expectancy
- Alcohol abuse or dependence
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Low-income status
- Documented diagnosis of T1D
- 18 years of age or older
- Federally Qualified Health Center (FQHC) primary care provider
- English or Spanish-speaking And at intervention sites
- Willingness to wear a CGM sensor
- Adult family member or friend, who will give consent to participate in the study and co-attend the 4-week intervention sessions
- Reported difficulty in using CGM if current or past use of CGM
Who cannot take part
- Serious illness that may prevent study participation (e.g., severe depression)
- Uncorrected hearing or vision impairment
- Pregnancy or planning to become pregnant
- Lactation
- Less than 6 months life expectancy
- Alcohol abuse or dependence
Where in United States
- Community Health Center, Inc.Middletown, United StatesEnrolling by invitation
- Treasure Coast Community HealthVero Beach, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
Low-income adults with type 1 diabetes (T1D), despite their disproportionate burden of acute complications (hypoglycemia and diabetes ketoacidosis) and related emergency department visits, hospitalizations, and death, remain largely disenfranchised from continuous glucose monitoring (CGM), an efficacious technology to mitigate these inequities. To increase CGM uptake in low-income, adults with T1D receiving diabetes management in federally qualified health centers (FQHCs), this pilot randomized control trial (RCT), will assess the feasibility of our study protocol, including our multi-level intervention informed by the Socio-Ecological Model.
The 2 groups in the trial
- Continuous Glucose Monitoring (CGM) Intervention ArmTreatment being tested
The intervention arm comprises participants receiving care from FQHC sites randomized to deliver the intervention. This arm will receive the 6-month, SEM-informed intervention to promote CGM uptake and maintenance.
Treatment: CGM Intervention
- Self-Monitoring of Blood Glucose (SMBG) ArmOther group
The SMBG control arm comprises participants receiving care from FQHC sites randomized to deliver the control condition. This arm will receive the 6-month control condition.
Treatment: SMBG Control Condition
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pilot RCT: FQHC Intervention for Uptake of CGM in Low-Income Adults With T1D
- Plain-language title
- Helping low-income adults with type 1 diabetes start continuous glucose monitoringGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Record updated
- 12 August 2025